Top Glove Corporation Bhd. (TGLVY)
USD 1.06
(0.0%)
USD 1.06
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 7.06 Billion MYR | -13.0% |
| 2022 | 8.11 Billion MYR | -17.03% |
| 2021 | 9.78 Billion MYR | 12.36% |
| 2020 | 8.7 Billion MYR | 53.05% |
| 2019 | 5.68 Billion MYR | 7.92% |
| 2018 | 5.27 Billion MYR | 79.5% |
| 2017 | 2.93 Billion MYR | 10.84% |
| 2016 | 2.64 Billion MYR | -1.44% |
| 2015 | 2.68 Billion MYR | 39.04% |
| 2014 | 1.93 Billion MYR | 9.13% |
| 2013 | 1.77 Billion MYR | 10.85% |
| 2012 | 1.59 Billion MYR | 12.3% |
| 2011 | 1.42 Billion MYR | 3.72% |
| 2010 | 1.37 Billion MYR | 21.16% |
| 2009 | 1.13 Billion MYR | 2.06% |
| 2008 | 1.1 Billion MYR | 5.31% |
| 2007 | 1.05 Billion MYR | 38.25% |
| 2006 | 762.11 Million MYR | 50.47% |
| 2005 | 506.5 Million MYR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 6.92 Billion MYR | -1.03% |
| 2024 Q1 | 7.01 Billion MYR | -0.61% |
| 2024 Q2 | 6.99 Billion MYR | -0.33% |
| 2023 Q2 | 7.59 Billion MYR | -1.63% |
| 2023 Q1 | 7.71 Billion MYR | -4.91% |
| 2023 Q3 | 7.6 Billion MYR | 0.11% |
| 2023 FY | 7.06 Billion MYR | -13.0% |
| 2023 Q4 | 7.06 Billion MYR | -7.1% |
| 2022 Q3 | 8.47 Billion MYR | -2.33% |
| 2022 FY | 8.11 Billion MYR | -17.03% |
| 2022 Q1 | 9.01 Billion MYR | -7.82% |
| 2022 Q4 | 8.11 Billion MYR | -4.2% |
| 2022 Q2 | 8.67 Billion MYR | -3.8% |
| 2021 Q2 | 12.4 Billion MYR | 21.0% |
| 2021 Q4 | 9.78 Billion MYR | -20.91% |
| 2021 FY | 9.78 Billion MYR | 12.36% |
| 2021 Q3 | 12.36 Billion MYR | -0.33% |
| 2021 Q1 | 10.25 Billion MYR | 17.8% |
| 2020 FY | 8.7 Billion MYR | 53.05% |
| 2020 Q1 | 5.84 Billion MYR | 2.69% |
| 2020 Q3 | 7.39 Billion MYR | 3.49% |
| 2020 Q4 | 8.7 Billion MYR | 17.65% |
| 2020 Q2 | 7.15 Billion MYR | 22.41% |
| 2019 Q4 | 5.68 Billion MYR | 2.82% |
| 2019 FY | 5.68 Billion MYR | 7.92% |
| 2019 Q1 | 5.37 Billion MYR | 1.98% |
| 2019 Q3 | 5.53 Billion MYR | 4.0% |
| 2019 Q2 | 5.31 Billion MYR | -1.03% |
| 2018 Q1 | 2.98 Billion MYR | 1.52% |
| 2018 Q4 | 5.27 Billion MYR | 4.15% |
| 2018 Q3 | 5.06 Billion MYR | 55.18% |
| 2018 FY | 5.27 Billion MYR | 79.5% |
| 2018 Q2 | 3.26 Billion MYR | 9.4% |
| 2017 Q2 | 2.78 Billion MYR | 1.3% |
| 2017 Q1 | 2.74 Billion MYR | 3.62% |
| 2017 Q3 | 2.79 Billion MYR | 0.36% |
| 2017 FY | 2.93 Billion MYR | 10.84% |
| 2017 Q4 | 2.93 Billion MYR | 5.21% |
| 2016 FY | 2.64 Billion MYR | -1.44% |
| 2016 Q4 | 2.64 Billion MYR | -0.37% |
| 2016 Q3 | 2.65 Billion MYR | -0.99% |
| 2016 Q2 | 2.68 Billion MYR | -1.76% |
| 2016 Q1 | 2.73 Billion MYR | 1.71% |
| 2015 Q3 | 2.45 Billion MYR | 8.73% |
| 2015 FY | 2.68 Billion MYR | 39.04% |
| 2015 Q1 | 2.16 Billion MYR | 12.11% |
| 2015 Q2 | 2.25 Billion MYR | 4.07% |
| 2015 Q4 | 2.68 Billion MYR | 9.6% |
| 2014 Q1 | 1.78 Billion MYR | 0.53% |
| 2014 Q3 | 1.97 Billion MYR | 6.1% |
| 2014 Q2 | 1.86 Billion MYR | 4.45% |
| 2014 FY | 1.93 Billion MYR | 9.13% |
| 2014 Q4 | 1.93 Billion MYR | -2.05% |
| 2013 Q4 | 1.77 Billion MYR | 2.64% |
| 2013 Q2 | 1.69 Billion MYR | 1.08% |
| 2013 Q1 | 1.67 Billion MYR | 4.98% |
| 2013 FY | 1.77 Billion MYR | 10.85% |
| 2013 Q3 | 1.72 Billion MYR | 1.77% |
| 2012 FY | 1.59 Billion MYR | 12.3% |
| 2012 Q3 | 1.58 Billion MYR | 6.06% |
| 2012 Q2 | 1.49 Billion MYR | 0.0% |
| 2012 Q4 | 1.59 Billion MYR | 0.6% |
| 2011 Q4 | 1.42 Billion MYR | 0.0% |
| 2011 FY | 1.42 Billion MYR | 3.72% |
| 2010 FY | 1.37 Billion MYR | 21.16% |
| 2009 FY | 1.13 Billion MYR | 2.06% |
| 2008 FY | 1.1 Billion MYR | 5.31% |
| 2007 FY | 1.05 Billion MYR | 38.25% |
| 2006 FY | 762.11 Million MYR | 50.47% |
| 2005 FY | 506.5 Million MYR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -384086.044% |
| Ansell Limited | 3.23 Billion USD | -118.183% |
| Ansell Limited | 3.24 Billion USD | -117.775% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -1344.118% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -2350919.769% |
| Psykey, Inc. | 1.72 Million USD | -408707.081% |
| ConvaTec Group Plc | 3.7 Billion USD | -90.418% |
| ConvaTec Group Plc | 3.71 Billion USD | -90.149% |
| Encision Inc. | 3.81 Million USD | -185208.22% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -1083160.595% |
| LifePoint, Inc. | 8.8 Million USD | -80061.573% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -44156.518% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -788902.235% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -128548.473% |
| Reflect Scientific, Inc. | 2.66 Million USD | -264486.986% |
| SmileDirectClub, Inc. | 597.06 Million USD | -1082.718% |
| Sector 10, Inc. | 1000.00 USD | -706156900.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | -48.783% |
| SheerVision, Inc. | 837.56 Thousand USD | -843007.102% |
| United Health Products, Inc. | 284.64 Thousand USD | -2480751.453% |
| Vasamed, Inc. | 1.6 Million USD | -441181.105% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -3164068.605% |
| Yubo International Biotech Limited | 2.34 Million USD | -300577.737% |